Menu
Federal Contractor Misconduct Database (FCMD)
The federal government routinely awards contracts to companies with
histories of misconduct, including
…
contract fraud and other
violations. POGO believes that providing this website will help to
improve contracting decisions and increase public knowledge of how
the government spends billions of taxpayer dollars each year.
Read more…
China Subsidiary Bribery Investigation
GlaxoSmithKline agreed to pay $20 million to settle Securities and Exchange Commission (SEC) charges of violating the Foreign Corrupt Practices Act (FCPA) when its China-based subsidiaries engaged in pay-to-prescribe schemes to increase sales. An SEC investigation found that the schemes took place between at least 2010 and June 2013 and involved the transfer of money, gifts, and other things of value to Chinese officials, which led to millions of dollars in increased sales of Glaxo products. The SEC found that Glaxo violated the FCPA’s internal controls and books-and-records provisions. Glaxo consented to the order without admitting or denying the findings.
- Misconduct Type
- Securities
- Enforcement Agency
- SEC
- Contracting Party
- None
- Court Type
- Administrative
- Disposition
- Settlement
- Date of Order
- 9/30/2016